|
1
|
Locatello LG, De Zan ER, Tarantini A, Lanzetta P, Miani C. External dacryocystorhinostomy: A critical overview of the current evidence. Eur J Ophthalmol 2024:11206721241249214. [PMID: 38689455 DOI: 10.1177/11206721241249214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/02/2024]
Abstract
PURPOSE External dacryocystorhinostomy (ext-DCR) is still considered the gold standard in the treatment of distal lacrimal duct obstruction. Despite an overall high success rate, some patients do relapse after surgery and the ideal perioperative management has not been identified yet. The purpose of this study is to critically discuss the published evidence in the last five years on the medical and surgical management of external dacryocystorhinostomy. Furthermore, the drawbacks of the available literature and the perspectives in this field will be also highlighted. METHODS Systematic review of the literature in the last 5 years by using PubMed and Google Scholar. RESULTS A total of 64 articles were included. Many technical modifications and surgical refinements have been proposed but a formal comparison among the various techniques is hampered by methodological heterogeneity. The use of local anesthesia, and the perioperative adjunctive techniques to reduce the risk of restenosis are also gaining popularity but the level of evidence remains weak. CONCLUSION Ext-DCR offers satisfactory clinical outcomes even though there are many gray areas that need to be addressed in future high-quality studies.
Collapse
Affiliation(s)
- Luca Giovanni Locatello
- Department of Otorhinolaryngology, Academic Hospital "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy
| | | | - Anna Tarantini
- Department of Medicine - Ophthalmology , University of Udine, Udine, Italy
| | - Paolo Lanzetta
- Department of Medicine - Ophthalmology , University of Udine, Udine, Italy
- Istituto Europeo di Microchirurgia Oculare (IEMO), Udine and Milan, Italy
- University of Udine, Department of Medicine (DAME), Via Colugna 50, 33100 Udine, Italy
| | - Cesare Miani
- Department of Otorhinolaryngology, Academic Hospital "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy
- University of Udine, Department of Medicine (DAME), Via Colugna 50, 33100 Udine, Italy
| |
Collapse
|
|
2
|
Pace GM, Giombi F, Muci G, Giunta G, Pirola F, Serra E, Zuppardo J, Ferreli F, Vinciguerra P, Mercante G, Maria AD, Spriano G, Malvezzi L. Outcomes of Endoscopic Endonasal Dacryocystorhinostomy in Glaucoma Patients. J Pers Med 2024; 14:348. [PMID: 38672975 PMCID: PMC11050967 DOI: 10.3390/jpm14040348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2024] [Revised: 03/22/2024] [Accepted: 03/25/2024] [Indexed: 04/28/2024] Open
Abstract
BACKGROUND Anti-glaucoma eye drops have been investigated due to their production of fibrotic changes on the conjunctival surface, undermining the functioning of the upper lacrimal drainage system. We aimed to assess whether these effects may impair the effectiveness of endoscopic endonasal dacryocystorhinostomy (EE-DCR). METHODS This is a single-center observational retrospective study on EE-DCR via a posterior approach. Resolution of epiphora and dacryocystitis were analyzed after 1 (T1) and 6-months (T2) from surgery. Surgical success was defined as anatomical (patency at irrigation, no recurring dacryocystitis) or complete (zeroing of Munk score). RESULTS Twenty patients (32 sides) were enrolled. Preoperatively, 93.75% (n = 30/32) presented severe (Munk 3-4) epiphora and 68.75% (n = 22/32) recurrent dacryocystitis. At T1, 50.0% (n = 16/32) were referred with residual epiphora (Munk ≥ 1) and 18.75% (n = 6/32) dacryocystitis. At T2, 31.25% (n = 10/32) still complained of epiphora (Munk ≥ 1) and 6.25% (n = 2/32) dacryocystitis. Difference of outcomes at aggregate and paired timepoints (except for T1 versus T2) resulted in statistical significance (p < 0.05). At T2, 22 (68.75%) complete, 8 (25.0%) anatomical successes and 2 (6.25%) surgical failures were observed. CONCLUSIONS Despite the chronic uptake of anti-glaucoma eye drops, EE-DCR guaranteed high rates of clinical relief from epiphora and remarkable decreases in the rates of recurrent dacryocystitis.
Collapse
Affiliation(s)
- Gian Marco Pace
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; (G.M.P.); (G.M.); (G.G.); (E.S.); (J.Z.); (F.F.); (P.V.); (G.M.); (A.D.M.); (G.S.); (L.M.)
- Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy;
| | - Francesco Giombi
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; (G.M.P.); (G.M.); (G.G.); (E.S.); (J.Z.); (F.F.); (P.V.); (G.M.); (A.D.M.); (G.S.); (L.M.)
- Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy;
| | - Giovanna Muci
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; (G.M.P.); (G.M.); (G.G.); (E.S.); (J.Z.); (F.F.); (P.V.); (G.M.); (A.D.M.); (G.S.); (L.M.)
| | - Gianmarco Giunta
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; (G.M.P.); (G.M.); (G.G.); (E.S.); (J.Z.); (F.F.); (P.V.); (G.M.); (A.D.M.); (G.S.); (L.M.)
| | - Francesca Pirola
- Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy;
| | - Egidio Serra
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; (G.M.P.); (G.M.); (G.G.); (E.S.); (J.Z.); (F.F.); (P.V.); (G.M.); (A.D.M.); (G.S.); (L.M.)
- Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy;
| | - Jessica Zuppardo
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; (G.M.P.); (G.M.); (G.G.); (E.S.); (J.Z.); (F.F.); (P.V.); (G.M.); (A.D.M.); (G.S.); (L.M.)
- Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy;
| | - Fabio Ferreli
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; (G.M.P.); (G.M.); (G.G.); (E.S.); (J.Z.); (F.F.); (P.V.); (G.M.); (A.D.M.); (G.S.); (L.M.)
- Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy;
| | - Paolo Vinciguerra
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; (G.M.P.); (G.M.); (G.G.); (E.S.); (J.Z.); (F.F.); (P.V.); (G.M.); (A.D.M.); (G.S.); (L.M.)
- Department of Ophthalmology, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy
| | - Giuseppe Mercante
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; (G.M.P.); (G.M.); (G.G.); (E.S.); (J.Z.); (F.F.); (P.V.); (G.M.); (A.D.M.); (G.S.); (L.M.)
- Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy;
| | - Alessandra Di Maria
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; (G.M.P.); (G.M.); (G.G.); (E.S.); (J.Z.); (F.F.); (P.V.); (G.M.); (A.D.M.); (G.S.); (L.M.)
- Department of Ophthalmology, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy
| | - Giuseppe Spriano
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; (G.M.P.); (G.M.); (G.G.); (E.S.); (J.Z.); (F.F.); (P.V.); (G.M.); (A.D.M.); (G.S.); (L.M.)
- Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy;
| | - Luca Malvezzi
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; (G.M.P.); (G.M.); (G.G.); (E.S.); (J.Z.); (F.F.); (P.V.); (G.M.); (A.D.M.); (G.S.); (L.M.)
- Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy;
- Otorhinolaryngology Head and Neck Surgery Unit, Casa di Cura Humanitas San Pio X, Via Francesco Nava 31, 20159 Milan, Italy
| |
Collapse
|
|
3
|
Lee SE, Lim HB, Oh S, Lee K, Lee SB. Effects of Topical Anti-Glaucoma Medications on Outcomes of Endoscopic Dacryocystorhinostomy: Comparison with Age- and Sex-Matched Controls. J Clin Med 2024; 13:634. [PMID: 38276140 PMCID: PMC10817280 DOI: 10.3390/jcm13020634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2023] [Revised: 01/15/2024] [Accepted: 01/19/2024] [Indexed: 01/27/2024] Open
Abstract
BACKGROUND This study analyzed the effects of topical anti-glaucoma medications on the surgical outcomes of endoscopic dacryocystorhinostomy (EDCR) in nasolacrimal duct obstruction (NLDO). METHODS This retrospective study included patients who underwent EDCR for NLDO between September 2012 and April 2021. Thirty patients with topical anti-glaucoma medications and 90 age- and sex-matched controls were included. RESULTS The success rate of EDCR was higher in the control group than in the anti-glaucoma group (97.8% vs. 86.7%, p = 0.034). Univariate and multivariate logistic regression analyses identified prostaglandin analogs as the most influential risk factor for EDCR success among anti-glaucoma medication ingredients (p = 0.005). The success rate of the group containing all four anti-glaucoma medication ingredients was statistically significant (p = 0.010). The success rate was significantly different in the group of patients who used anti-glaucoma medication for >24 months (p = 0.019). When multiplying the number of drug ingredients by the duration in months, the group > 69 showed a significantly decreased success rate (p = 0.022). Multivariate logistic regression analysis identified the number of anti-glaucoma medications as the most significant risk factor for EDCR success (odds ratio, 0.437; 95% confidence interval, 0.247 to 0.772; p = 0.004). CONCLUSIONS The authors suggest that the anti-glaucoma medications might cause NLDO and increase the failure rate after EDCR. Therefore, when performing EDCR in patients using topical anti-glaucoma medications, surgeons should consider the possibility of increased recurrence after EDCR in clinical outcomes.
Collapse
Affiliation(s)
- Seong Eun Lee
- Department of Ophthalmology, Chungbuk National University Hospital, College of Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea; (S.E.L.); (K.L.)
- Department of Ophthalmology, College of Medicine, Chungbuk National University, Daejeon 35015, Republic of Korea; (S.O.)
| | - Hyung Bin Lim
- Department of Ophthalmology, College of Medicine, Chungbuk National University, Daejeon 35015, Republic of Korea; (S.O.)
- 1.0 Eye Clinic, Daejeon 34946, Republic of Korea; (H.B.L.)
| | - Seungjun Oh
- Department of Ophthalmology, College of Medicine, Chungbuk National University, Daejeon 35015, Republic of Korea; (S.O.)
| | - Kibum Lee
- Department of Ophthalmology, Chungbuk National University Hospital, College of Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea; (S.E.L.); (K.L.)
| | - Sung Bok Lee
- Department of Ophthalmology, College of Medicine, Chungbuk National University, Daejeon 35015, Republic of Korea; (S.O.)
| |
Collapse
|